CME Group Inc. (NASDAQ:CME) Analyst Ratings as of Jun 27, 2018

June 27, 2018 - By Fidelia Bagby

CME Group Inc. (NASDAQ:CME) Corporate Logo
During 2018 Q1 the big money sentiment decreased to 1.12. That’s change of 0.03, from 2017Q4’s 1.15. 42 investors sold all, 238 reduced holdings as CME Group Inc. ratio fall. 218 grew positions while 95 funds acquired positions. Funds hold 263.44 million shares thus 0.87% less from 2017Q4’s 265.76 million shares.
Bokf Na holds 0.29% of its capital in CME Group Inc. (NASDAQ:CME) for 64,070 shs. Cibc Inc has invested 0.01% of its capital in CME Group Inc. (NASDAQ:CME). Canada Pension Plan Invest Board owns 815,157 shs for 0.22% of their capital. Blair William And Il has invested 0.18% in CME Group Inc. (NASDAQ:CME). Thrivent For Lutherans owns 14,201 shs. First Allied Advisory has invested 0.02% in CME Group Inc. (NASDAQ:CME). 364 are owned by Smithfield Tru. Capital Guardian Comm accumulated 649,491 shs or 1.48% of the stock. Citizens And Northern holds 0.48% or 3,952 shs. Moreover, Chem State Bank has 0.04% invested in CME Group Inc. (NASDAQ:CME) for 2,002 shs. Plante Moran Advisors Lc invested 0.04% in CME Group Inc. (NASDAQ:CME). Johnson Group has 0% invested in CME Group Inc. (NASDAQ:CME) for 227 shs. 5,593 were accumulated by Brinker. Barclays Plc holds 0.09% of its capital in CME Group Inc. (NASDAQ:CME) for 740,442 shs. 32,588 are owned by Jump Trading Limited Co.

CME Group Inc. registered $14.24 million net activity with 0 insider purchases and 15 selling transactions since January 9, 2018. DUFFY TERRENCE A sold $3.03 million worth of CME Group Inc. (NASDAQ:CME) or 20,000 shs on Tuesday, February 6. On Monday, February 5 a trade for 7,300 shs valued at $1.14 million was made by MELAMED LEO. Pankau Ronald A. also sold $42,878 worth of CME Group Inc. (NASDAQ:CME) on Thursday, June 7. On Monday, May 21 Bernacchi Jeffrey M. sold $614,372 worth of CME Group Inc. (NASDAQ:CME). Shares for $876,471 were sold by CRONIN KATHLEEN M on Thursday, May 31. On Tuesday, February 20 $539,452 worth of CME Group Inc. (NASDAQ:CME) was sold by Piell Hilda Harris.

CME Group Inc. (NASDAQ:CME) Ratings Coverage

Total analysts of 9 have positions in CME Group (NASDAQ:CME) as follows: 7 rated it a “Buy”, 0 with “Sell” and 2 with “Hold”. The positive are 78%. Since January 16, 2018 according to StockzIntelligence Inc CME Group has 14 analyst reports. On Friday, March 9 the rating was maintained by Jefferies with “Buy”. On Tuesday, January 16 the firm has “Buy” rating given by Jefferies. The company rating was maintained by Deutsche Bank on Friday, April 6. On Tuesday, April 10 the firm earned “Buy” rating by Jefferies. On Monday, February 26 the stock of CME Group Inc. (NASDAQ:CME) has “Hold” rating given by Keefe Bruyette & Woods. On Friday, March 2 the company was maintained by Sandler O’Neill. In Thursday, March 8 report Bank of America maintained it with “Buy” rating and $185 target. In Friday, February 2 report Barclays Capital maintained it with “Overweight” rating and $175 target. On Thursday, February 1 the firm earned “Buy” rating by Sandler O’Neill. The stock rating was maintained by Bank of America with “Buy” on Friday, February 2. Listed here are CME Group Inc. (NASDAQ:CME) PTs and latest ratings.

10/04/2018 Broker: Jefferies Rating: Buy New Target: $190.0000 Maintain
10/04/2018 Broker: Bernstein Rating: Outperform New Target: $190 Initiates Coverage On
06/04/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Buy Old Target: $185 New Target: $197 Maintain
09/03/2018 Broker: Jefferies Rating: Buy New Target: $187.0 Maintain
08/03/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $175 New Target: $185 Maintain
02/03/2018 Broker: Sandler O’Neill Rating: Buy New Target: $185.0 Maintain
26/02/2018 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $168.0 Maintain
07/02/2018 Broker: Goldman Sachs Rating: Buy New Target: $180.0 Upgrade
02/02/2018 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $161.0 Maintain
02/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $173 New Target: $175 Maintain

CME is hitting $166.18 during the last trading session, after increased 0.38%.CME Group Inc. has volume of 494,249 shares. Since June 27, 2017 CME has risen 38.43% and is uptrending. The stock outperformed the S&P500 by 25.86%.

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.The firm is valued at $56.59 billion. The firm offers a range of products across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals.13.28 is the P/E ratio. The Company’s products include exchange-traded; and privately negotiated futures and options contracts and swaps.

A couple more CME Group Inc. (NASDAQ:CME) news were brought out by: Seekingalpha.com which released on June 25, 2018 “Too Many Trading Platforms; Nothing New To Trade”, also Nasdaq.com on June 15, 2018 brought out “Trade of the Day: CME Group Inc (CME)”, the next Seekingalpha.com is “Capitalizing On The Next Market Crash” on May 30, 2018. Nasdaq.com has article titled “With GE Gone, It’s Time to Stop Covering the Dow Jones Index”.

CME Group Inc. (NASDAQ:CME) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: